Stopping Mounjaro or Wegovy? What Happens to Your Weight

Two drugs have quietly reshaped how urban India thinks about weight. Mounjaro (tirzepatide, from Eli Lilly) arrived in March 2025, and Wegovy (semaglutide, from Novo Nordisk) followed in June. They work — people genuinely drop 15% to 23% of their body weight. But almost every conversation in a clinic or a WhatsApp group skips the question that matters most: what happens when you stop the GLP-1 weight loss jab? The honest answer is that, for most people, the weight comes back. Here is what to expect, and how to leave the drug without erasing months of effort.

How these jabs actually work

Neither drug melts fat directly. They mimic gut hormones your body releases after a meal. Semaglutide copies one such hormone, GLP-1; tirzepatide copies two, GLP-1 and GIP, which is part of why it tends to deliver bigger numbers.

The effect is mostly in your head and your stomach. Appetite drops, cravings quieten, and the stomach empties more slowly so you feel full on far less food. People who once cleared a full thali find half of it overwhelming. You eat less without grinding willpower against hunger all day — and the weight follows.

That mechanism is also the catch. The drug manages your appetite for as long as it is in your system. It does not retrain your hunger signals permanently or rewrite your metabolism. Take the lever away, and the lever stops working.

The regain almost nobody plans for

When you stop, hunger returns — often sharper than before, because a lighter body burns fewer calories at rest. Studies that followed people after they came off semaglutide found they regained roughly two-thirds of the weight they had lost within about a year. Some of the metabolic improvements, like better blood sugar and blood pressure, faded along with it.

This is not a failure of character. It is the predictable result of removing a drug that was doing a specific job. Yet most first-time users go in imagining a finish line: lose the weight, stop the jab, keep the new body. That framing sets people up for a demoralising bounce-back.

The more useful mental model is the one a growing number of obesity doctors now use. They treat obesity as a chronic condition, like high blood pressure — something you manage on an ongoing basis rather than cure in a six-month course. Under that view, stopping cold is the exception, not the plan.

What it costs to stay on, and to stop

Money drives a lot of these decisions in India, so the numbers matter. As of 2026, Mounjaro runs from about ₹13,125 a month at the 2.5 mg starting dose to roughly ₹25,781 at the top 15 mg dose. Wegovy, after Novo Nordisk cut prices by as much as 48% in 2026 to compete, starts near ₹5,660 a month for the lowest dose and climbs with strength.

For many households, that is the real reason the jab stops — not a goal reached, but a bill that no longer fits. Insurance rarely covers it for weight loss. So the practical question is not just "should I stop" but "if cost forces my hand, how do I hold on to the results."

That reframes the spending too. Money put into protein-rich food, a gym membership or a few sessions with a trainer is not a side expense while you are on the drug. It is the part of the plan that keeps working after the injections stop.

The muscle you don't want to lose

There is a second, quieter problem. When you lose weight fast on appetite suppression, a chunk of what disappears is muscle, not just fat. Estimates vary, but a meaningful share — by some measures a quarter to a third of total weight lost — can be lean mass.

Losing muscle is bad on every front. It lowers your resting metabolism, which makes regain easier and faster. It weakens you. And for older Indians already prone to low muscle mass and weak bones, it is a real risk, not a cosmetic one.

Two habits protect against it, and both should start the day you start the drug, not the day you stop:

• Eat enough protein. Aim higher than usual, since you are eating less overall. Dal, paneer, eggs, curd, soya, chicken or fish at every meal, plus a supplement if you fall short.
• Do resistance training. Two or three sessions a week of weights or bodyweight work signals your body to keep muscle. Walking is good for the heart; it does little to defend muscle.

Building an exit before you ever inject

The people who keep the weight off treat the jab as a head start, not the whole race. The drug buys you a window of low appetite — use it to install habits that survive without it.

1. Decide the goal upfront. Is this a temporary reset before a health event, or long-term management? The plan looks very different, and your doctor should help you choose.
2. Don't quit abruptly. Tapering the dose down, rather than stopping overnight, gives your appetite a gentler runway. Discuss a step-down schedule.
3. Consider a maintenance dose. Many patients stay on a lower dose long term to hold their loss, which can also cost less than the peak dose.
4. Lock in habits while appetite is low. Build the protein-first plate, the training routine and the sleep schedule now, so they are automatic before hunger returns.
5. Track more than the scale. Waist measurement, strength and energy tell you whether you are losing fat or muscle. The number alone hides that.

Who should think twice

These are powerful prescription drugs, not lifestyle accessories, and they are not for everyone chasing a slimmer photo. They are meant for people with obesity or with serious weight-related conditions, used under medical supervision.

Side effects are common, mostly nausea, vomiting and constipation, and usually ease over time. Rarer but serious risks include pancreatitis and gallbladder trouble. Anyone with a personal or family history of a specific thyroid cancer is generally told to avoid them. None of this should be self-managed off a pharmacy counter or a grey-market vial bought online — a route that has become disturbingly common and carries real danger from fakes and wrong dosing.

The bottom line is unglamorous but freeing. Mounjaro and Wegovy are excellent tools for losing weight, and lousy tools for keeping it off by themselves. The injection does the hard early work; the food, the muscle and the plan for life after the last dose decide whether any of it lasts.